2.1. Analysis.
Comparison 2 Cavosonstat (N91115) (200 mg twice daily) versus placebo, Outcome 1 CFQR respiratory domain: absolute change from baseline.
Comparison 2 Cavosonstat (N91115) (200 mg twice daily) versus placebo, Outcome 1 CFQR respiratory domain: absolute change from baseline.